» Articles » PMID: 36923301

Second Dose Measles Vaccination Utilization and Associated Factors in Jabitehnan District, Northwest Ethiopia

Overview
Journal Dose Response
Publisher Sage Publications
Date 2023 Mar 16
PMID 36923301
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Herd immunity against measles is essential to interrupt measles transmission, and this can only be attained by reaching at least 95% coverage for each of the 2 doses of measles vaccine provided in infancy and early childhood age group. It is important to provide everyone with 2 doses of the measles vaccine in order to effectively safeguard the population. Despite this, little is known about the second dosage of the measles vaccine utilization status and the factors that affect it. Therefore, this study aimed to assess second dose of measles vaccination utilization and its associated factors among children aged 24-35 months in Jabitehnan district, 2020.

Methods: A community-based cross-sectional study design was conducted at Jabitehnan District, Northwest Ethiopia, from September 1st, 2020 to October 1st, 2020. Systematic random sampling technique was used to select 845 mothers/caregivers who had children aged 24-35 months. Both bi-variable and multivariable logistic regression was fitted to identify the determinant factors of second dose measles vaccination utilization. Finally, the statistical significant variables were declared by using 95% CI and value less than .05 in the multivariable logistic regression analysis. The Hosmer and Lemeshow test was used to check the model's fit to the data, and the variance inflation factor was used to assess multi-collinearity.

Results: The overall second dose of measles vaccination utilization was 48.1%, (95% CI: 44.7-51.6). Mothers with primary school education (AOR = 1.91, 95% CI: 1.15-3.17), information about MCV2 (AOR = 6.53, 95% CI: 4.22-10.08), distance from vaccination site (AOR = 3.56, 95% CI: 2.46-5.14), knowledge about immunization (AOR = 1.935, 95% CI: 1.29-2.90), and favorable attitude about immunization (AOR = 5.19, 95% CI: 3.25-8.29) were significantly associated factors with second dose of measles vaccination utilization.

Conclusion: Second dose measles vaccination utilization in the district was lower than the national target. Maternal education, distances from vaccination site, information about MCV2, and knowledge about immunization were significantly associated variables with second dose measles vaccination utilization. Therefore, in order to increase the utilization of the second dose of the measles vaccine, improved health education and service expansion to difficult-to-reach areas are required.

Citing Articles

Uptake of Measles Second Dose Vaccine and Its Associated Factors Among Children Age 24-35 Months in Merhabete Woreda, Ethiopia: 2022: A Cross-Sectional Study.

Wmeskel A, Zergaw M, Abocherugn H Health Sci Rep. 2024; 7(12):e70278.

PMID: 39698530 PMC: 11652380. DOI: 10.1002/hsr2.70278.


Mapping the Implementation Determinants of Second Dose Measles Vaccination in the World Health Organization African Region: A Rapid Review.

Adamu A, Jalo R, Masresha B, Ndwandwe D, Wiysonge C Vaccines (Basel). 2024; 12(8).

PMID: 39204023 PMC: 11359529. DOI: 10.3390/vaccines12080896.


Measles second dose vaccine uptake and associated factors among under-five children in Jigjiga City, Somali Region, Eastern Ethiopia: a community-based cross-sectional study.

Ibrahim H, Wariyo A, Asefa E, Cheru A, Lonsako A, Dirirsa G Front Public Health. 2024; 12:1395802.

PMID: 39139669 PMC: 11319266. DOI: 10.3389/fpubh.2024.1395802.


Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia.

Solomon K, Aksnes B, Woyessa A, Sadi C, Geri C, Matanock A Vaccines (Basel). 2024; 12(7).

PMID: 39066340 PMC: 11281509. DOI: 10.3390/vaccines12070702.


Second dose of measles-containing vaccine coverage and associated factors among children aged 24-36 months in Gondar city, Central Gondar, Northwest Ethiopia, 2023.

Adisu M, Bogale W, Alemu T Front Public Health. 2024; 12:1364865.

PMID: 38756896 PMC: 11097900. DOI: 10.3389/fpubh.2024.1364865.


References
1.
Klett-Tammen C, Krause G, Seefeld L, Ott J . Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health. 2016; 16:121. PMC: 4743086. DOI: 10.1186/s12889-016-2784-8. View

2.
Fernandez R, Awofeso N, Rammohan A . Determinants of apparent rural-urban differentials in measles vaccination uptake in Indonesia. Rural Remote Health. 2011; 11(3):1702. View

3.
Lin W, Xiong Y, Tang H, Chen B, Ni J . Factors associated with delayed measles vaccination among children in Shenzhen, China: a case-control study. Hum Vaccin Immunother. 2015; 10(12):3601-6. PMC: 4514074. DOI: 10.4161/21645515.2014.979687. View

4.
Hu Y, Chen Y, Wang Y, Liang H . Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China. Hum Vaccin Immunother. 2017; 14(4):875-880. PMC: 5893191. DOI: 10.1080/21645515.2017.1419111. View

5.
Goodson J, Masresha B, Wannemuehler K, Uzicanin A, Cochi S . Changing epidemiology of measles in Africa. J Infect Dis. 2011; 204 Suppl 1:S205-14. DOI: 10.1093/infdis/jir129. View